ZTEK
ZEN Graphene Solutions Ltd
NASDAQ: ZTEK · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$0.49
+0.00% today
Updated 2026-09-02
Market cap
$62.30M
P/E ratio
—
P/S ratio
575.48x
EPS (TTM)
$-0.07
Dividend yield
—
52W range
$0 – $1
Volume
0.2M
WallStSmart proprietary scores
15
out of 100
Grade: F
Strong Sell
Investment rating
5.3
Growth
C+6.0
Quality
B2.5
Profitability
F4.0
Valuation
C1/9
Piotroski F-Score
Weak
-9.8
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →261 stocks currently score above 75
Price targets
Analyst target
—
—
12-Month target
—
—
Intrinsic (DCF)
$0.54
Margin of safety
-21.17%
Price chart
Stock snapshot
Strengths
+ Debt/equity 0.08x — low leverage
Risks
- Piotroski 1/9 — weak financial health
- Altman Z -9.81 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-1.76M
- Revenue declining -95.50% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2023 | 2024 | 2025 | 2026 | TTM |
|---|---|---|---|---|---|
| Revenue | $72855.00 | $29816.00 | $872495.00 | $166476.00 | $108250.00 |
| Net income | $-14.41M | $-11.70M | $-10.04M | $-9.79M | $-2.04M |
| EPS | — | — | — | — | $-0.07 |
| Free cash flow | $-15.23M | $-6.18M | $-6.28M | $-5.08M | $-1.76M |
| Profit margin | -19,784.87% | -39,254.06% | -1,150.68% | -5,882.65% | — |
Peer comparison
Smart narrative
ZEN Graphene Solutions Ltd trades at $0.49. Our Smart Value Score of 15/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of -9.81, it sits in the distress. TTM revenue stands at $108250.00. Our DCF model estimates intrinsic value at $0.54.
Frequently asked questions
What is ZEN Graphene Solutions Ltd's stock price?
ZEN Graphene Solutions Ltd (ZTEK) trades at $0.49, on a P/S of 575.5x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is ZEN Graphene Solutions Ltd overvalued?
ZEN Graphene Solutions Ltd carries a Smart Value Score of 15/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read. On valuation specifically, our conservative DCF puts intrinsic value at $0.54 against the $0.49 price, so on cash flow terms the market is paying a premium for ZEN Graphene Solutions Ltd's growth. The Strong Sell rating reflects that growth and quality, while the DCF flags that the price already assumes a lot.
What is the intrinsic value of ZEN Graphene Solutions Ltd (ZTEK)?
Our DCF model estimates intrinsic value at $0.54, a -21.2% margin of safety versus today's $0.49. Intrinsic value is what the projected cash flows are worth today. A negative reading means the price is running ahead of that conservative estimate, leaving little downside cushion if growth slows.
What is ZEN Graphene Solutions Ltd's revenue?
ZEN Graphene Solutions Ltd's trailing twelve-month revenue is $108250.00. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
ZEN Graphene Solutions Ltd's Altman Z-Score is -9.81, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryMEDICAL INSTRUMENTS & SUPPLIES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio575.48x
ROE-65.52%
Beta0.29
50D MA$0.55
200D MA$0.62
Shares out0.13B
Float0.12B
Short ratio—
Avg volume0.2M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—